Accuracy of Second Trimester Prediction of Preterm Preeclampsia by 3 Different Screening Algorithms. Issue 1 (March 2019)

• Record Type: Journal Article
• Authors: Al-Amin, A.; Rolnik, D.L.; Black, C.; White, A.; Stolarek, C.; Brennecke, S.; da Silva Costa, F.
• Is Part Of: Obstetric anesthesia digest. Volume 39:Issue 1(2019)
• Publication Date: 2019-03
• Subjects: Preeclampsia/eclampsia; Anesthesia in obstetrics -- Periodicals; Anesthesia in obstetrics -- Abstracts -- Periodicals; 617.968205
• DOI: 10.1097/01.aoa.0000552910.82459.67
• Languages: English
• ISSNs: 0275-665X

Abstract

Abstract : ( Aust N Z J Obstet Gynaecol . 2018;58:192–196) Preeclampsia (PE) is a major risk factor for maternal and perinatal morbidity and mortality. Thus, early screening in the first trimester to identify patients at high risk for PE allows the initiation of early preventive measures, such as low-dose aspirin therapy begun before 16 weeks gestation. Many women, though, do not have their first prenatal visit until after 16 weeks, and identifying high-risk patients in the second trimester can still be beneficial, especially for identifying early signs of PE and providing timely treatment. Currently, the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has guidelines for identifying at risk women using maternal demographics and medical history. Likewise in the United States, the American College of Obstetricians and Gynecologists (ACOG) have recommendations for screening that uses demographics and medical history to define those women considered at high risk for PE. In contrast, the Fetal Medicine Foundation (FMF) has published an algorithm for identifying women at risk for early PE that includes measurement of mean arterial pressure and uterine artery Doppler pulsatility index in addition to medical history. This prospective nonintervention study aimed to compare the efficacy of these three screening methods used during the second trimester to predict the occurrence of PE.